BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 20181616)

  • 41. Functional characterization of the promoter region of the human EVI1 gene in acute myeloid leukemia: RUNX1 and ELK1 directly regulate its transcription.
    Maicas M; Vázquez I; Vicente C; García-Sánchez MA; Marcotegui N; Urquiza L; Calasanz MJ; Odero MD
    Oncogene; 2013 Apr; 32(16):2069-78. PubMed ID: 22689058
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Low Mpl receptor expression in a pedigree with familial platelet disorder with predisposition to acute myelogenous leukemia and a novel AML1 mutation.
    Heller PG; Glembotsky AC; Gandhi MJ; Cummings CL; Pirola CJ; Marta RF; Kornblihtt LI; Drachman JG; Molinas FC
    Blood; 2005 Jun; 105(12):4664-70. PubMed ID: 15741216
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Epidermis contains platelet-type 12-lipoxygenase that is overexpressed in germinal layer keratinocytes in psoriasis.
    Hussain H; Shornick LP; Shannon VR; Wilson JD; Funk CD; Pentland AP; Holtzman MJ
    Am J Physiol; 1994 Jan; 266(1 Pt 1):C243-53. PubMed ID: 8304420
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expression of arachidonate platelet-type 12-lipoxygenase in human rheumatoid arthritis type B synoviocytes.
    Liagre B; Vergne P; Rigaud M; Beneytout JL
    FEBS Lett; 1997 Sep; 414(1):159-64. PubMed ID: 9305751
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Leukemia Inhibitory Factor Receptor Gene Is a Direct Target of RUNX1.
    Qadi AA; Taberlay PC; Phillips JL; Young A; West AC; Brettingham-Moore KH; Dickinson JL; Holloway AF
    J Cell Biochem; 2016 Jan; 117(1):49-58. PubMed ID: 26060100
    [TBL] [Abstract][Full Text] [Related]  

  • 46. SERPINB13 is a novel RUNX1 target gene.
    Boyapati A; Ren B; Zhang DE
    Biochem Biophys Res Commun; 2011 Jul; 411(1):115-20. PubMed ID: 21723253
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Boswellic acids stimulate arachidonic acid release and 12-lipoxygenase activity in human platelets independent of Ca2+ and differentially interact with platelet-type 12-lipoxygenase.
    Poeckel D; Tausch L; Kather N; Jauch J; Werz O
    Mol Pharmacol; 2006 Sep; 70(3):1071-8. PubMed ID: 16788089
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of adenine nucleotides on cyclooxygenase and lipoxygenase enzyme products of arachidonic acid in human platelets.
    Dragan YP; Ellis EF
    Biochem Pharmacol; 1990 Jan; 39(1):27-32. PubMed ID: 2105095
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Induction of cyclooxygenase-2 gene in pancreatic beta-cells by 12-lipoxygenase pathway product 12-hydroxyeicosatetraenoic acid.
    Han X; Chen S; Sun Y; Nadler JL; Bleich D
    Mol Endocrinol; 2002 Sep; 16(9):2145-54. PubMed ID: 12198250
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Induction of 12-lipoxygenase expression by phorbol 12-myristate 13-acetate in human epidermoid carcinoma A431 cells.
    Liaw YW; Liu YW; Chen BK; Chang WC
    Biochim Biophys Acta; 1998 Jan; 1389(1):23-33. PubMed ID: 9443600
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Platelet-type 12-lipoxygenase activates NF-kappaB in prostate cancer cells.
    Kandouz M; Nie D; Pidgeon GP; Krishnamoorthy S; Maddipati KR; Honn KV
    Prostaglandins Other Lipid Mediat; 2003 Jul; 71(3-4):189-204. PubMed ID: 14518561
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibition of arachidonate lipoxygenase12 targets lung cancer through inhibiting EMT and suppressing RhoA and NF-κB activity.
    Chen J; Tong W; Liao M; Chen D
    Biochem Biophys Res Commun; 2020 Apr; 524(4):803-809. PubMed ID: 32037090
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Platelet microparticles are internalized in neutrophils via the concerted activity of 12-lipoxygenase and secreted phospholipase A2-IIA.
    Duchez AC; Boudreau LH; Naika GS; Bollinger J; Belleannée C; Cloutier N; Laffont B; Mendoza-Villarroel RE; Lévesque T; Rollet-Labelle E; Rousseau M; Allaeys I; Tremblay JJ; Poubelle PE; Lambeau G; Pouliot M; Provost P; Soulet D; Gelb MH; Boilard E
    Proc Natl Acad Sci U S A; 2015 Jul; 112(27):E3564-73. PubMed ID: 26106157
    [TBL] [Abstract][Full Text] [Related]  

  • 54. c-sis/platelet-derived growth factor-B promoter requirements for induction during the 12-O-tetradecanoylphorbol-13-acetate-mediated megakaryoblastic differentiation of K562 human erythroleukemia cells.
    Kujoth GC; Fahl WE
    Cell Growth Differ; 1997 Sep; 8(9):963-77. PubMed ID: 9300179
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Platelet transcriptome analysis in patients with germline RUNX1 mutations.
    Palma-Barqueros V; Bastida JM; López Andreo MJ; Zámora-Cánovas A; Zaninetti C; Ruiz-Pividal JF; Bohdan N; Padilla J; Teruel-Montoya R; Marín-Quilez A; Revilla N; Sánchez-Fuentes A; Rodriguez-Alen A; Benito R; Vicente V; Iturbe T; Greinacher A; Lozano ML; Rivera J; ;
    J Thromb Haemost; 2023 May; 21(5):1352-1365. PubMed ID: 36736831
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Periovulatory expression of hyaluronan and proteoglycan link protein 1 (Hapln1) in the rat ovary: hormonal regulation and potential function.
    Liu J; Park ES; Curry TE; Jo M
    Mol Endocrinol; 2010 Jun; 24(6):1203-17. PubMed ID: 20339004
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Aberrant expression of the P2 promoter-specific transcript Runx1 in epiphyseal cartilage of Trps1-null mice.
    Kanno S; Gui T; Itoh S; Gai Z; Sun Y; Oikawa K; Yoshida M; Muragaki Y
    Exp Mol Pathol; 2011 Apr; 90(2):143-8. PubMed ID: 21122804
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 5-lipoxygenase-activating protein gene expression. Key role of CCAAT/enhancer-binding proteins (C/EBP) in constitutive and tumor necrosis factor (TNF) alpha-induced expression in THP-1 cells.
    Reddy KV; Serio KJ; Hodulik CR; Bigby TD
    J Biol Chem; 2003 Apr; 278(16):13810-8. PubMed ID: 12571239
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Functional classification of RUNX1 variants in familial platelet disorder with associated myeloid malignancies.
    Decker M; Lammens T; Ferster A; Erlacher M; Yoshimi A; Niemeyer CM; Ernst MPT; Raaijmakers MHGP; Duployez N; Flaum A; Steinemann D; Schlegelberger B; Illig T; Ripperger T
    Leukemia; 2021 Nov; 35(11):3304-3308. PubMed ID: 33692461
    [No Abstract]   [Full Text] [Related]  

  • 60. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
    Zhou D; Masri S; Ye JJ; Chen S
    Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.